Alerts will be sent to your verified email
Verify Email
FRANKLININD
|
Franklin Industries
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.91 % | 0.21 % | -1.34 % |
|
5yr average Equity Multiplier
|
2.12 | 1.01 | 1.52 |
|
5yr Average Asset Turnover Ratio
|
1.95 | 0.02 | 0.3 |
|
5yr Avg Net Profit Margin
|
4.47 % | -19.83 % | -13.9 % |
|
Price to Book
|
0.92 | 1.05 | 0.32 |
|
P/E
|
3.14 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
41.88 Days | 0.0 | 765.04 Days |
|
Inventory Days
|
14.53 Days | 0.0 | 113.07 Days |
|
Days Receivable
|
80.91 Days | 0.0 | 916.46 Days |
|
Days Payable
|
89.3 Days | 1109.22 Days | 375.27 Days |
|
5yr Average Interest Coverage Ratio
|
91.56 | 902.8 | 1.54 |
|
5yr Avg ROCE
|
29.97 % | 0.21 % | 3.66 % |
|
5yr Avg Operating Profit Margin
|
7.0 % | -19.88 % | -2.53 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.11 |
|
5yr CAGR Net Profit
|
204.43 % | n/a | n/a |
|
5yr Average Return on Assets
|
8.95 % | 0.21 % | -0.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.0 | 0.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -4.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Franklin Industries
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|